2024-04-02 05:36:53 ET
Summary
- Boston Scientific has rallied nearly 40% over the past year, driving its market value to a milestone of $100 billion for the first time.
- We preview BSX's upcoming Q1 earnings report set to be released on April 26th.
- While the company benefits from solid fundamentals, we believe near-term upside in the stock is limited with many of the positives already priced in.
Boston Scientific ( BSX ) has reached a market capitalization of $100 billion into "mega-cap" status following a spectacular 40% rally over the past year. The story has been a string of quarterly earnings exceeding expectations, with the medical devices leader capturing a growth resurgence....
Read the full article on Seeking Alpha
For further details see:
Boston Scientific: The Market's Newest Mega-Cap Needs A Breather